Guy Chouinard, MD, MSc
Axe de recherche primaire:
Maladies mentales et toxicomanie
Courriel:
Courriel Le but de la recherche:
Symptômes de la schizophrénie, symptômes extrapyramidaux médicamenteux, mouvements anormaux et suicidalité, emploi des antiépileptiques en psychiatrie, dangerosité, dépression.Psychopharmacologie, antipsychotiques, antiépileptiques, hypnotiques-anxiolytiques, schizophrénie, antidépresseurs
Mots-clés:
Psychopharmacologie, antipsychotiques, antiépileptiques, hypnotiques-anxiolytiques, schizophrénie, antidépresseurs
Emplacement:
Royal Victoria Hospital Publications:
Chouinard G, Chouinard VA, Corruble E: Beyond DSM-IV Bereavement Exclusion Criterion E for Major Depressive Disorder. Psychother Psychosom (Epub Oct 23; 80(1) 4-9 2010) 80: 804-9; 2011
Chouinard G, Chouinard VA.Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom 77(2): 69-77; 2008
Chouinard G, Miller R. A new Rating Scale for Psychotic Symptoms (RSPS). Part I. Theoretical Principles and Subscale 1: Perception Symptoms (Hallucinations and Illusions). Schizophrenia Research 38:101-122 ; 1999
Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Journal of Clinical Psychiatry; 47:32-37; 1985
Chouinard G, Labonte A, Fontaine R, Annable L. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines. Progress in Neuro-Psychopharmacology and Biological Psychiatry; 7: 669-673 ; 1983
